Hypoactive sexual desire disorder

The new drug Flibanserin, being sold as Addyi, is now available for women – premenopausal women – who experience low sexual desire. The battle for FDA approval was a heated one, fraught with misconceptions, huge outpourings of money from Sprout Pharmaceuticals, and cries of gender bias in the FDA approval process. Addyi is not a …